Evidence map›Paper›PMID 34169363›Full record

ArticleEsophagus : official journal of the Japan Esophageal Society2021

Creation and provision of a question and answer resource for esophageal cancer based on medical professionals' reports of patients' and families' views and preferences.

Yasushi Toh, Yoji Inoue, Masayo Hayakawa, Chikako Yamaki, Hiroya Takeuchi, Masaichi Ohira, Hisahiro Matsubara, Yuichiro Doki, Fumihiko Wakao, Tomoko Takayama

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Esophagus : official journal of the Japan Esophageal Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Yasushi TohThe Japan Esophageal Society, Tokyo, Japan.
Yoji InoueDivision of Cancer Information Services, Center for Cancer Control and Information Service, National Cancer Center, Tokyo, Japan.
Masayo HayakawaDivision of Cancer Information Services, Center for Cancer Control and Information Service, National Cancer Center, Tokyo, Japan.
Chikako YamakiDivision of Cancer Information Services, Center for Cancer Control and Information Service, National Cancer Center, Tokyo, Japan.
Hiroya TakeuchiThe Japan Esophageal Society, Tokyo, Japan.
Masaichi OhiraThe Japan Esophageal Society, Tokyo, Japan.
Hisahiro MatsubaraThe Japan Esophageal Society, Tokyo, Japan.
Yuichiro DokiThe Japan Esophageal Society, Tokyo, Japan.
Fumihiko WakaoCenter for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan.
Tomoko TakayamaDivision of Cancer Information Services, Center for Cancer Control and Information Service, National Cancer Center, Tokyo, Japan. totakaya@ncc.go.jp.ORCID 0000-0001-8150-3272
Chiba University · JPHamamatsu University School of Medicine · JPNational Cancer Center · USNational Hospital Organization Kyushu Cancer Center · JPOsaka City University · JPThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the rapidly-progressing healthcare environment, it is essential to improve treatment quality through continuous clarification of the needs and concerns of esophageal cancer patients and their families. Effective collaboration between information providers and academic associations could help make such clarified information available.

methodsWe analyzed esophageal cancer patients' views and preferences (PVPs) using data that were previously obtained from medical staff in Japan. Based on these PVPs, we created a question and answer (Q&A) resource through collaboration with the Cancer Information Service in Japan (CISJ) and the Japan Esophageal Society (JES).

resultsRegarding esophageal cancer, "diet and eating behavior" was the most frequent PVP mentioned by patients and their families, followed by "treatment-related symptoms and adverse effects" and "daily life, recuperation, and survivorship." These PVPs were noted by a wide variety of medical specialties. By analyzing the PVPs, the CISJ developed 11 proposed questions and sent them to the JES, which then created answers based on evidence and clinical-practice-associated consensus. The resultant Q&A resource was uploaded to the CISJ website with mutual linkage to the JES website.

conclusionsThis study showed the usefulness of collecting esophageal-cancer-related PVPs from medical staff and fostering successful collaboration between a cancer-information provider and an academic association. This arrangement may represent a model case for developing a sustainable system that can satisfactorily respond to PVPs regarding other cancers and/or issues.

Indexed as

Esophageal NeoplasmsConsensusHumansJapanAcademies and institutesEsophageal neoplasmsEvidence-based practiceHealth communicationQuality of health care

Identifiers

PMID34169363
PMCPMC8387257
OpenAlexW3176102991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.